Published in Gastroenterology on June 01, 1999
Case-control study on the association of upper gastrointestinal bleeding and nonsteroidal anti-inflammatory drugs in Japan. Eur J Clin Pharmacol (2006) 1.33
Cyclooxygenase 2-implications on maintenance of gastric mucosal integrity and ulcer healing: controversial issues and perspectives. Gut (2001) 1.29
The association of Helicobacter pylori infection and nonsteroidal anti-inflammatory drugs in peptic ulcer disease. Can J Gastroenterol (2006) 0.98
Contraindicated NSAIDs are frequently prescribed to elderly patients with peptic ulcer disease. Br J Clin Pharmacol (2002) 0.96
Role of Helicobacter pylori eradication in aspirin or non-steroidal anti-inflammatory drug users. World J Gastroenterol (2005) 0.95
Effects of nonsteroidal anti-inflammatory drugs on Helicobacter pylori-infected gastric mucosae of mice: apoptosis, cell proliferation, and inflammatory activity. Infect Immun (2001) 0.91
Biphasic effects of H. pylori infection on low-dose aspirin-induced gastropathy depending on the gastric acid secretion level. J Gastroenterol (2012) 0.83
Gastric acid secretion level modulates the association between Helicobacter pylori infection and low-dose aspirin-induced gastropathy. J Gastroenterol (2011) 0.80
NSAID gastric ulceration: predictive value of gastric pH, mucosal density of polymorphonuclear leukocytes, or levels of IL-8 or nitrite. Dig Dis Sci (2002) 0.79
Approach to Helicobacter pylori infection in geriatric population. World J Gastrointest Pharmacol Ther (2014) 0.78
Aspirin injury and H pylori. Gut (2002) 0.75
Acid-reducing vagotomy is associated with reduced risk of subsequent ischemic heart disease in complicated peptic ulcer: An Asian population study. Medicine (Baltimore) (2016) 0.75
Role of Helicobacter pylori infection in gastroduodenal damage in patients starting NSAID therapy: 4 Months follow-up study. Dig Dis Sci (2010) 0.75
H. pylori and risk of ulcer bleeding among users of NSAIDS. Gastroenterology (2000) 0.75
The Danish prescription registries. Dan Med Bull (1997) 5.04
The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol (1998) 3.04
A placebo-controlled, double-blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease. N Engl J Med (1989) 2.71
Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response. Scand J Gastroenterol (1997) 2.02
Effect of omeprazole and cimetidine on duodenal ulcer. A double-blind comparative trial. N Engl J Med (1985) 1.98
Statins and risk of polyneuropathy: a case-control study. Neurology (2002) 1.97
On demand therapy with omeprazole for the long-term management of patients with heartburn without oesophagitis--a placebo-controlled randomized trial. Aliment Pharmacol Ther (1999) 1.80
Quality of life in patients with heartburn but without esophagitis: effects of treatment with omeprazole. Am J Gastroenterol (1999) 1.74
A randomized comparative study of esomeprazole 40 mg versus pantoprazole 40 mg for healing erosive oesophagitis: the EXPO study. Aliment Pharmacol Ther (2005) 1.70
Effects of topical 5-aminosalicylic acid and prednisolone on prostaglandin E2 and leukotriene B4 levels determined by equilibrium in vivo dialysis of rectum in relapsing ulcerative colitis. Gastroenterology (1986) 1.67
Effect of profound acid suppression in functional dyspepsia: a double-blind, randomized, placebo-controlled trial. Scand J Gastroenterol (2002) 1.66
The role of acid suppression in patients with endoscopy-negative reflux disease: the effect of treatment with esomeprazole or omeprazole. Aliment Pharmacol Ther (2004) 1.64
Colonic azodisalicylate metabolism determined by in vivo dialysis in healthy volunteers and patients with ulcerative colitis. Gastroenterology (1984) 1.62
Omeprazole and ranitidine in treatment of reflux oesophagitis: double blind comparative trial. Br Med J (Clin Res Ed) (1988) 1.59
Helicobacter pylori test and eradicate versus prompt endoscopy for management of dyspeptic patients: 6.7 year follow up of a randomised trial. Gut (2004) 1.55
The Nordic prescription databases as a resource for pharmacoepidemiological research--a literature review. Pharmacoepidemiol Drug Saf (2013) 1.53
Polypharmacy: correlations with sex, age and drug regimen. A prescription database study. Eur J Clin Pharmacol (1998) 1.46
Methods for estimating the occurrence of polypharmacy by means of a prescription database. Eur J Clin Pharmacol (1997) 1.43
Low-dose cyclosporin for Crohn's disease: implications for clinical trials. Aliment Pharmacol Ther (1989) 1.42
[Antabus treatment in general practice. A pharmaco-epidemiological study of prescription patterns based on a prescription database]. Ugeskr Laeger (1998) 1.41
Comorbidity in elderly cancer patients in relation to overall and cancer-specific mortality. Br J Cancer (2012) 1.38
Quality assurance of data: ensuring that numbers reflect operational definitions and contain real measurements. Int J Tuberc Lung Dis (2011) 1.36
Why has the search for causes of low back pain largely been nonconclusive? Spine (Phila Pa 1976) (1997) 1.31
Prevalence of atopic dermatitis, asthma, allergic rhinitis, and hand and contact dermatitis in adolescents. The Odense Adolescence Cohort Study on Atopic Diseases and Dermatitis. Br J Dermatol (2001) 1.27
The relationship between paroxetine and the sparteine oxidation polymorphism. Clin Pharmacol Ther (1992) 1.26
Are young adults with asthma treated sufficiently with inhaled steroids? A population-based study of prescription data from 1991 and 1994. Br J Clin Pharmacol (1996) 1.25
Guillain-Barré syndrome: diagnostic criteria, epidemiology, clinical course and prognosis. Acta Neurol Scand (1988) 1.23
Use of sumatriptan in Denmark in 1994-5: an epidemiological analysis of nationwide prescription data. Br J Clin Pharmacol (1997) 1.22
Selective 5-lipoxygenase inhibition in ulcerative colitis. Lancet (1990) 1.21
Short time-frame from first to second hip fracture in the Funen County Hip Fracture Study. Osteoporos Int (2006) 1.20
Effect of azodisal sodium and sulphasalazine on ileostomy output of fluid and PGE2 and PGF2 alpha in subjects with a permanent ileostomy. Gut (1986) 1.20
Epidemiology of NSAID-related gastroduodenal mucosal injury. Best Pract Res Clin Gastroenterol (2001) 1.18
Validation of seven graded diary cards for severity of dyspeptic symptoms in patients with non ulcer dyspepsia. Eur J Surg Suppl (1998) 1.16
Lipid-lowering drugs and risk of myopathy: a population-based follow-up study. Epidemiology (2001) 1.15
Non-steroidal anti-inflammatory drugs and ulcer complications: a risk factor analysis for clinical decision-making. Scand J Gastroenterol (1996) 1.13
Polypharmacy in general practice: differences between practitioners. Br J Gen Pract (1999) 1.12
The prevalence of low back pain in the literature. A structured review of 26 Nordic studies from 1954 to 1993. Spine (Phila Pa 1976) (1995) 1.12
Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-oesophageal reflux disease: a controlled trial of 'on-demand' therapy for 6 months. Aliment Pharmacol Ther (2001) 1.09
Drug prescribing among Danish children: a population-based study. Eur J Clin Pharmacol (2001) 1.08
An analysis of seven different methods to diagnose Helicobacter pylori infections. Scand J Gastroenterol (1998) 1.08
Comparison of ranitidine and high-dose antacid in the treatment of prepyloric or duodenal ulcer. A double-blind controlled trial. Scand J Gastroenterol (1985) 1.07
Is it possible to predict treatment response to a proton pump inhibitor in functional dyspepsia? Aliment Pharmacol Ther (2003) 1.04
Use of statins and risk of glioma: a nationwide case-control study in Denmark. Br J Cancer (2013) 1.02
Completeness and consistency in recording information in the tuberculosis case register, Cambodia, China and Viet Nam. Int J Tuberc Lung Dis (2010) 1.02
Polypharmacy and the risk of drug-drug interactions among Danish elderly. A prescription database study. Dan Med Bull (1998) 1.02
Quantitative differences in sputum smear microscopy results for acid-fast bacilli by age and sex in four countries. Int J Tuberc Lung Dis (2009) 1.01
Dose finding study of mosapride in functional dyspepsia: a placebo-controlled, randomized study. Aliment Pharmacol Ther (2002) 1.00
Changes in body weight and tuberculosis treatment outcome in Viet Nam. Int J Tuberc Lung Dis (2012) 1.00
Use of anti-secretory medication: a population-based cohort study. Aliment Pharmacol Ther (2004) 0.97
Is overuse of sumatriptan a problem? A population-based study. Eur J Clin Pharmacol (1996) 0.96
There is an association between selective serotonin reuptake inhibitor use and uncomplicated peptic ulcers: a population-based case-control study. Aliment Pharmacol Ther (2010) 0.96
The mephenytoin oxidation polymorphism is partially responsible for the N-demethylation of imipramine. Clin Pharmacol Ther (1991) 0.96
Trends in utilization of antiepileptic drugs in Denmark. Acta Neurol Scand (2006) 0.96
Omeprazole in the long-term treatment of gastro-oesophageal reflux disease. A double-blind randomized dose-finding study. Scand J Gastroenterol (1995) 0.95
Outpatient utilization of antidepressants: a prescription database analysis. J Affect Disord (1993) 0.94
Cancer incidence among mild steel and stainless steel welders and other metal workers. Am J Ind Med (1996) 0.94
Antiepileptic drug utilization: a Danish prescription database analysis. Acta Neurol Scand (2001) 0.92
Enprostil and ranitidine in prevention of duodenal ulcer relapse: one year double blind comparative trial. Br Med J (Clin Res Ed) (1987) 0.92
Time off work after occupational hand injuries. J Hand Surg Br (1999) 0.90
Inappropriate use of sumatriptan: population based register and interview study. BMJ (1998) 0.90
Randomized-controlled trial of esomeprazole in functional dyspepsia patients with epigastric pain or burning: does a 1-week trial of acid suppression predict symptom response? Aliment Pharmacol Ther (2007) 0.90
Final report on a placebo-controlled, double-blind, randomized, multicentre trial of cyclosporin treatment in active chronic Crohn's disease. Scand J Gastroenterol (1991) 0.90
Are users of lipid-lowering drugs at increased risk of peripheral neuropathy? Eur J Clin Pharmacol (2001) 0.89
Esomeprazole 20 mg vs. pantoprazole 20 mg for maintenance therapy of healed erosive oesophagitis: results from the EXPO study. Aliment Pharmacol Ther (2005) 0.88
Enprostil and ranitidine in duodenal ulcer healing: double blind comparative trial. Br Med J (Clin Res Ed) (1986) 0.88
Use of low-dose aspirin and non-aspirin nonsteroidal anti-inflammatory drugs and risk of glioma: a case-control study. Br J Cancer (2013) 0.87
Switch from systemic steroids to budesonide in steroid dependent patients with inactive Crohn's disease. Gut (2001) 0.87
The potential role of acid suppression in functional dyspepsia: the BOND, OPERA, PILOT, and ENCORE studies. Gut (2002) 0.87
Manganese exposure in foundry furnacemen and scrap recycling workers. Int Arch Occup Environ Health (1999) 0.87
5-Lipoxygenase inhibitors for the treatment of inflammatory bowel disease. Agents Actions (1992) 0.87
5-Aminosalicylic acid in the treatment of Crohn's disease. A 16-week double-blind, placebo-controlled, multicentre study with Pentasa. Scand J Gastroenterol (1987) 0.86
Drug-induced symptoms of functional dyspepsia and nausea. A symmetry analysis of one million prescriptions. Aliment Pharmacol Ther (2000) 0.86
Incidence of unintentional injuries in farming based on one year of weekly registration in Danish farms. Am J Ind Med (2000) 0.85
Symptomatic recurrence of healed duodenal and prepyloric ulcers after treatment with ranitidine or high-dose antacid. A 1-year follow-up study. Scand J Gastroenterol (1986) 0.85
Sputum smear-positive tuberculosis: empiric evidence challenges the need for confirmatory smears. Int J Tuberc Lung Dis (2007) 0.85
One-week acid suppression trial in uninvestigated dyspepsia patients with epigastric pain or burning to predict response to 8 weeks' treatment with esomeprazole: a randomized, placebo-controlled study. Aliment Pharmacol Ther (2007) 0.85
Self-administered symptom questionnaires in patients with dyspepsia and their yield in discriminating between endoscopic diagnoses. Dig Dis (2002) 0.84
One-week triple therapy with esomeprazole provides effective eradication of Helicobacter pylori in duodenal ulcer disease. Aliment Pharmacol Ther (2000) 0.83
Validation of an ELISA for the diagnosis of recent Campylobacter infections in Guillain-Barré and reactive arthritis patients. Clin Microbiol Infect (2007) 0.82
Serum concentrations of orosomucoid: improved decision-making for tapering prednisolone therapy in patients with active inflammatory bowel disease? Scand J Gastroenterol (1997) 0.82
Concurrent use of more than one major psychotropic drug (polypsychopharmacy) in out-patients--a prescription database study. Br J Clin Pharmacol (1994) 0.82
Making pragmatic sense of data in the tuberculosis laboratory register. Int J Tuberc Lung Dis (2008) 0.81
Efficacy of omeprazole in lower grades of gastro-oesophageal reflux disease. Scand J Gastroenterol Suppl (1994) 0.81
Antidepressant treatment in general practice--an interview study. Scand J Prim Health Care (1995) 0.81
A case of Moraxella canis-associated wound infection. Scand J Infect Dis (2001) 0.81
Prescribing of acid suppressive therapy: interactions between hospital and primary care. Aliment Pharmacol Ther (2006) 0.80
Changes in the pattern of antidepressant use upon the introduction of the new antidepressants: a prescription database study. Eur J Clin Pharmacol (1997) 0.80
Drugs and femoral neck fracture: a case-control study. J Intern Med (1991) 0.79
Risk of non-melanoma skin cancer in myasthenia patients treated with azathioprine. Eur J Neurol (2013) 0.79
Randomised clinical trial: the burden of illness of uninvestigated dyspepsia before and after treatment with esomeprazole--results from the STARS II study. Aliment Pharmacol Ther (2011) 0.79
Use of azathioprine for non-thymoma myasthenia and risk of cancer: a nationwide case-control study in Denmark. Eur J Neurol (2013) 0.79
[Occupational hand injuries. A population-based description of the incidence and referral to casualty departments]. Ugeskr Laeger (1999) 0.78
5-Aminosalicylic acid in the treatment of inflammatory bowel disease. Acta Med Scand (1987) 0.78
Ultrasonically guided subclavian vein catheterization. Acta Radiol (1989) 0.78
National surveillance of Helicobacter pylori eradication therapy in Denmark. Results from registration of 34,582 prescriptions. Scand J Gastroenterol (1998) 0.78
Prostaglandin analogues. Baillieres Clin Gastroenterol (1988) 0.78